Fluocinonide

Last updated

Fluocinonide
Fluocinonide.png
Clinical data
Trade names Fluonex, Lidex, others [1]
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a601054
Routes of
administration
Topical
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only)
  • US: WARNING [2] Rx-only
Pharmacokinetic data
Metabolism Liver
Identifiers
  • 6α,9-difluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,21-acetate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.005.998 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C26H32F2O7
Molar mass 494.532 g·mol−1
3D model (JSmol)
  • O=C(OCC(=O)[C@]45OC(O[C@@H]5C[C@@H]2[C@@]4(C[C@H](O)[C@]3(F)[C@]/1(/C=C\C(=O)\C=C\1[C@@H](F)C[C@@H]23)C)C)(C)C)C
  • InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1 Yes check.svgY
  • Key:WJOHZNCJWYWUJD-IUGZLZTKSA-N Yes check.svgY
   (verify)

Fluocinonide is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. [3] It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort. [3]

A common potential adverse effect is skin atrophy (thinning of the skin). [4]

In 2022, it was the 266th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [5] [6]

Veterinary uses

Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs. [7] Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure. [8]

References

  1. "Fluocinonide Topical". MedlinePlus Drug Information. U.S. National Library of Medicine.
  2. "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA . Retrieved 22 October 2023.
  3. 1 2 "Fluocinonide Topical: MedlinePlus Drug Information". medlineplus.gov. Retrieved 16 November 2022.
  4. Jablonska S, Groniowska M, Dabroswki J (February 1979). "Comparative evaluation of skin atrophy in man induced by topical corticoids". The British Journal of Dermatology. 100 (2): 193–206. doi:10.1111/j.1365-2133.1979.tb05561.x. PMID   154921. S2CID   30656827.
  5. "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  6. "Fluocinonide Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
  7. Dog Allergies. Squidoo (Report).
  8. Zenoble RD, Kemppainen RJ (September 1987). "Adrenocortical suppression by topically applied corticosteroids in healthy dogs". Journal of the American Veterinary Medical Association. 191 (6): 685–688. doi:10.2460/javma.1987.191.06.685. PMID   2824410.